🇺🇸 FDA
Patent

US 6569661

Recombinant &agr;-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof

expired A61KA61K38/00A61K48/00

Quick answer

US patent 6569661 (Recombinant &agr;-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof) held by BIOMARIN PHARMACEUTICAL INC. expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue May 27 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61K48/00, A61P, A61P19/00